Home > Healthcare > Healthcare Distribution Market > Table of Contents

Healthcare Distribution Market - By Type (Pharmaceutical [OTC, Generic, Branded Drugs], Biopharmaceutical [Vaccines, Monoclonal Antibodies], & Medical Device Distribution Services), End-use (Hospital, Retail Pharmacies) – Global Forecast (2024 – 2032)

  • Report ID: GMI9732
  • Published Date: Jun 2024
  • Report Format: PDF

Report Content

Chapter 1   Methodology & Scope

1.1    Market scope & definitions

1.2    Research design

1.2.1    Research approach

1.2.2    Data collection methods

1.3    Base estimates & calculations

1.3.1    Base year calculation

1.3.2    Key trends for market estimation

1.4    Forecast model

1.5    Primary research and validation

1.5.1    Primary sources

1.5.2    Data mining sources

Chapter 2   Executive Summary

2.1    Industry 3600 synopsis

Chapter 3   Industry Insights

3.1    Industry ecosystem analysis

3.2    Industry impact forces

3.2.1    Growth drivers

3.2.1.1    High incidence and large economic burden of chronic diseases

3.2.1.2    Favorable R&D investment scenario and subsequent increase in drug launches

3.2.1.3    Growth of track and trace solutions

3.2.1.4    Growing adoption of generic drugs

3.2.2    Industry pitfalls & challenges

3.2.2.1    High operational costs

3.2.2.2    Stringent regulatory compliance and changes

3.3    Growth potential analysis

3.4    Reimburesement scenario

3.5    Regulatory landscape

3.5.1    U.S.

3.5.2    Europe

3.5.3    Asia Pacific

3.6    Technological landscape

3.6.1    Core technologies

3.6.2    Adjacent technologies

3.7    Future market trends

3.8    Porter’s analysis

3.9    PESTEL analysis

Chapter 4   Competitive Landscape, 2023

4.1    Introduction

4.2    Company market share analysis

4.3    Company matrix analysis

4.4    Competitive analysis of major market players

4.5    Competitive positioning matrix

4.6    Strategy dashboard

Chapter 5   Market Estimates and Forecast, By Type, 2021 – 2032 ($ Mn)

5.1    Key trends

5.2    Pharmaceutical product distribution services

5.2.1    OTC drugs/vitamins

5.2.2    Generic drugs

5.2.3    Brand-name/innovator drugs

5.3    Biopharmaceutical product distribution services

5.3.1    Monoclonal antibodies

5.3.2    Vaccines

5.3.3    Recombinant proteins

5.3.4    Blood and blood products

5.3.5    Other products

5.4    Medical device distribution services

Chapter 6   Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)

6.1    Key trends

6.2    Hospital pharmacies

6.3    Retail pharmacies

6.4    Other end-users

Chapter 7   Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)

7.1    Key trends

7.2    North America

7.2.1    U.S.

7.2.2    Canada

7.3    Europe

7.3.1    Germany

7.3.2    UK

7.3.3    France

7.3.4    Spain

7.3.5    Italy

7.3.6    Netherlands

7.3.7    Rest of Europe

7.4    Asia Pacific

7.4.1    China

7.4.2    Japan

7.4.3    India

7.4.4    Australia

7.4.5    South Korea

7.4.6    Rest of Asia Pacific

7.5    Latin America

7.5.1    Brazil

7.5.2    Mexico

7.5.3    Argentina

7.5.4    Rest of Latin America

7.6    Middle East and Africa

7.6.1    South Africa

7.6.2    Saudi Arabia

7.6.3    UAE

7.6.4    Rest of Middle East and Africa

Chapter 8   Company Profiles

8.1    Alliance Healthcare

8.2    AmerisourceBergen Corporation

8.3    Anda, Inc.

8.4    Cardinal Health, Inc.

8.5    Celesio AG

8.6    CuraScript SD

8.7    Henry Schein, Inc.

8.8    McKesson Corporation

8.9    Medline Industries, Inc.

8.10    Morris & Dickson Co., LLC

8.11    Owens & Minor, Inc.

8.12    Patterson Companies, Inc.

8.13    Pheonix Group

8.14    Sinopharm Group

8.15    Suzuken Co., Ltd.
 

Authors: Mariam Faizullabhoy, Gauri Wani

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 15
  • Tables & Figures: 167
  • Countries covered: 23
  • Pages: 184
 Download Free Sample